News Q-linea AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:44 2024-05-20 am EDT			5-day change	1st Jan Change
2.12 ^SEK	-2.75%		-7.42%	-42.70%

Apr. 26	Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	CI
Mar. 13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI

Changed dates for Interim Report and Annual General Meeting	May. 15	AQ
Q-linea applies for a NTAP code for the US market	May. 03	AQ
Q-linea signs evaluation contract with reference laboratory network in the US	May. 02	AQ
Q-linea receives US FDA 510(k) clearance for the ASTar® System	Apr. 26	AQ
Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	Apr. 26	CI
Q-linea publish the Annual report for 2023	Apr. 12	AQ
Q linea : Strong ASTar results presented at AMCLI	Mar. 13	PU
Q-linea AB Presents Strong ASTar Results At AMCLI	Mar. 13	CI
Q-linea participates in tender for rapid AST	Mar. 05	AQ
Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Year-end report 1 January – 31 December 2023	Feb. 27	AQ
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 27	CI
Q-linea presents at AMCLI	Feb. 15	AQ
Q-linea Presents at AMCLI	Feb. 15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	Feb. 09	MT
Q-linea creates separate subsidiary for Podler	Feb. 09	AQ
Q-linea signs agreement with logistics partner for the American market	Feb. 08	AQ
Anders Ljunggren takes office as Managing Director of Q-linea AB on 1 March 2024	Feb. 01	AQ
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	Feb. 01	CI

No results for this search